NYSE:TBI - Trueblue Stock Price, Price Target & More

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue declared that its board has initiated a stock repurchase program on Tuesday, October 31st 2017, which permits the company to buyback $100,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board believes its shares are undervalued.

Trueblue Inc (NYSE:TBI) posted its quarterly earnings data on Monday, April, 30th. The business services provider reported $0.31 EPS for the quarter, beating the Zacks' consensus estimate of $0.22 by $0.09. The business services provider had revenue of $554.39 million for the quarter, compared to the consensus estimate of $570.40 million. Trueblue had a net margin of 2.39% and a return on equity of 13.81%. Trueblue's revenue for the quarter was down 2.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.21 EPS. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Trueblue.

Trueblue updated its second quarter earnings guidance on Monday, April, 30th. The company provided earnings per share guidance of $0.47-0.53 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.53. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $627.25 million.

2 Wall Street analysts have issued 1 year target prices for Trueblue's shares. Their forecasts range from $26.00 to $29.00. On average, they anticipate Trueblue's share price to reach $27.50 in the next twelve months. This suggests that the stock has a possible downside of 0.2%. View Analyst Ratings for Trueblue.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Trueblue include ASGN (ASGN), Insperity (NSP), Dometic Group AB (publ) (DTCGF), AMN Healthcare Services (AMN), TTEC (TTEC), Kforce (KFRC), Kelly Services, Inc. Class B (KELYB), Kelly Services, Inc. Class A (KELYA), Barrett Business Services (BBSI), SThree (STREF), Cross Country Healthcare (CCRN), StarTek (SRT), DLH (DLHC), R C M Technologies (RCMT) and Hudson Global (HSON).

Media stories about TBI stock have trended positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Trueblue earned a news impact score of 0.35 on Accern's scale. They also gave news coverage about the business services provider an impact score of 46.03 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Trueblue's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Bank of Montreal Can (0.29%) and Alpha Windward LLC (0.05%). Company insiders that own Trueblue stock include Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can. Company insiders that have sold Trueblue company stock in the last year include Bonnie W Soodik, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Insider Buying and Selling for Trueblue.

TBI stock was acquired by a variety of institutional investors in the last quarter, including Alpha Windward LLC. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $27.55.

Trueblue has a market capitalization of $1.12 billion and generates $2.51 billion in revenue each year. The business services provider earns $55.45 million in net income (profit) each year or $1.74 on an earnings per share basis. Trueblue employs 5,500 workers across the globe.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]